TRACLEER 32 mg, dispersible tablet 56 tablets
Active ingredients: Bosentan, Bosentan hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRACLEER 32 mg, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) thermoformée(s) aluminium "peel-push" de 14 comprimé(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Mar 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64186770CIP73993510CIP133400939935102Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BOSENTAN BASEcomprimé | 32 mg · un comprimé | FT |
| BOSENTAN MONOHYDRATÉcomprimé | 33,045 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.